Literature DB >> 20362558

Differential expression and alternative splicing of genes in lumbar spinal cord of an amyotrophic lateral sclerosis mouse model.

Huifang Chen1, Yansu Guo, Ming Hu, Weisong Duan, Geng Chang, Chunyan Li.   

Abstract

Amyotrophic lateral sclerosis (ALS) is one of the most common adult-onset neurodegenerative diseases, with progressive paralysis and muscle atrophy. The exact pathogenic mechanism remains unknown, but recent evidence suggests that differential gene expression and gene splicing may play a significant role. We used Affymetrix GeneChip Mouse Exon 1.0 ST Array to investigate the expression profiling of lumbar spinal cord samples from SOD1-G93A transgenic mice, the widely used animal model of ALS. The de-regulated genes analyzed either from the expression level or from the alternative splicing level both showed overlapping GO categories and pathway mapping. Our findings indicate that cell adhesion, immune-inflammation response and lipid metabolism all play important roles in the onset of ALS. Detailed analysis by RT-PCR of key genes confirmed the experimental results of microarrays. These results suggest a multi-factor mechanism in ALS development. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20362558     DOI: 10.1016/j.brainres.2010.03.075

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Wnt Signaling is altered by spinal cord neuronal dysfunction in amyotrophic lateral sclerosis transgenic mice.

Authors:  Li Yu; Yingjun Guan; Xin Wu; Yanchun Chen; Zhijun Liu; Hongmei Du; Xin Wang
Journal:  Neurochem Res       Date:  2013-06-20       Impact factor: 3.996

2.  Alternative splicing of apoptosis-related genes in imatinib-treated K562 cells identified by exon array analysis.

Authors:  Jing Liu; Yun Xiao; Huo-Mei Xiong; Jing Li; Bo Huang; Hai-Bin Zhang; Dan-Qin Feng; Xi-Min Chen; Xiao-Zhong Wang
Journal:  Int J Mol Med       Date:  2011-12-29       Impact factor: 4.101

3.  Using an exon microarray to identify a global profile of gene expression and alternative splicing in K562 cells exposed to sodium valproate.

Authors:  Xiang-Zhong Zhang; Ai-Hua Yin; Xiao-Yu Zhu; Qian Ding; Chun-Huai Wang; Yun-Xian Chen
Journal:  Oncol Rep       Date:  2011-12-21       Impact factor: 3.906

4.  Can transcriptomics cut the gordian knot of amyotrophic lateral sclerosis?

Authors:  Alexandre Henriques; Jose-Luis Gonzalez De Aguilar
Journal:  Curr Genomics       Date:  2011-11       Impact factor: 2.236

5.  From Transcriptome to Noncoding RNAs: Implications in ALS Mechanism.

Authors:  Stella Gagliardi; Pamela Milani; Valentina Sardone; Orietta Pansarasa; Cristina Cereda
Journal:  Neurol Res Int       Date:  2012-06-17

6.  Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis.

Authors:  Kevin X Liu; Benjamin Edwards; Sheena Lee; Mattéa J Finelli; Ben Davies; Kay E Davies; Peter L Oliver
Journal:  Brain       Date:  2015-03-09       Impact factor: 13.501

Review 7.  Investigating cell death mechanisms in amyotrophic lateral sclerosis using transcriptomics.

Authors:  Paul R Heath; Janine Kirby; Pamela J Shaw
Journal:  Front Cell Neurosci       Date:  2013-12-17       Impact factor: 5.505

8.  The peroxisome proliferator-activated receptor γ (PPARγ) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis.

Authors:  Valeria Benedusi; Francesca Martorana; Liliana Brambilla; Adriana Maggi; Daniela Rossi
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

9.  Transcriptome Profiling Following Neuronal and Glial Expression of ALS-Linked SOD1 in Drosophila.

Authors:  Emily L Kumimoto; Taylor R Fore; Bing Zhang
Journal:  G3 (Bethesda)       Date:  2013-04-09       Impact factor: 3.154

10.  Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice.

Authors:  Bradley J Turner; Neza Alfazema; Rebecca K Sheean; James N Sleigh; Kay E Davies; Malcolm K Horne; Kevin Talbot
Journal:  Neurobiol Aging       Date:  2013-10-24       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.